Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461070 · ClinicalTrials.gov registry record
Intestine Bacteria and Breast Cancer Risk
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 175
- Enrollment target
NCT01461070: Completed study, sponsored by National Cancer Institute (NCI).
NCT01461070 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461070 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Background: \- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by looking at stool and urine samples from postmenopausal women. Objectives: \- To study intestinal bacteria and its relationship to urine-based markers of breast cancer risk in women. Eligibility: \- Women between 55 and 69 years of age with a recent mammogram that showed no signs of cancer. Design: * Participants will be screened with a medical history and basic health questionnaire. * At home, participants will complete questionnaires about cancer risk factors and food consumption. * Participants will also collect urine and stool samples. They will send the samples to the designated labs for study. * No treatment will be provided as part of this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2011-08-10 |
| Est. Completion | 2020-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01461070
The ClinicalTrials.gov registry entry for NCT01461070 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01461070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01461070 about?
NCT01461070 is a clinical study titled "Intestine Bacteria and Breast Cancer Risk". Background: \- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by look...
What is the current status of trial NCT01461070?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2011-08-10. Estimated completion is 2020-05-22.
Who is sponsoring clinical trial NCT01461070?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.